Tolvaptan Extension Study in Participants With ADPKD

NCT01214421 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1083

Enrollment

INDUSTRY

Sponsor class

Conditions

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Interventions

DRUG: Tolvaptan

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.